₹0.00

Listing Status:
Chain of super specialty eye care hospitals. It offers a range of ophthalmology services, including cataract surgery, diabetic retinopathy treatment,...
Total Rounds: 7 Asgeyehospital
| S.No. | Date | Round Name | Amount | TTM Revenue | Investors & Facilitators |
|---|---|---|---|---|---|
| 1. | Jul 27, 2022 | Series D | ₹1,500 Cr | ₹333 Cr | Inst: General Atlantic, Kedaara, Foundation Holdings, Skyvision, Britten Holdings, Massive Impacts Angel: Shilpi, Arun Facil: Khaitan |
| 2. | Apr 29, 2020 | Series C | ₹40 Cr | ₹144 Cr | Inst: Britten Holdings, Care Holdings |
| 3. | Dec 10, 2019 | Series C | ₹110 Cr | ₹140 Cr | Inst: Care Holdings, Britten Holdings |
| 4. | Sep 18, 2019 | Series C | ₹306 Cr | ₹137 Cr | Inst: Foundation Holdings, Symphony International Holdings |
| 5. | Oct 4, 2017 | Series B | ₹65 Cr | ₹102 Cr | Inst: Investcorp |
| 6. | Sep 4, 2017 | Series B | ₹75 Cr | ₹100 Cr | Inst: IDFC Alternatives Facil: Allegro Advisors |
| 7. | Jan 15, 2013 | Series A | ₹64 Cr | - | Inst: Sequoia Capital |
| Detailed Income Statement | FY 24-25 (in Cr) |
|---|---|
| 1,145.1 | |
| 1,219.1 | |
| Total profit before exceptional items, extraordinary items and tax | (74.0) |
| Exceptional items before tax | (10.6) |
| Total profit before tax | (84.6) |
| (6.5) | |
| Total profit (loss) for period from continuing operations | (78.0) |
| Total profit (loss) for period | (78.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 24-25 (in Cr) |
|---|---|
| 2,722.6 | |
| 2,722.6 |
| Detailed Cash Flow Statement | FY 24-25 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | 170.5 |
| Net cash from / (used in) investing activities | (223.7) |
| Net cash from / (used) in financing activities | 183.4 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 130.3 |
| Net increase / (decrease) in cash and cash equivalents | 130.3 |
| Cash and cash equivalents at the beginning of the year | 30.2 |
| Cash and cash equivalents at the end of the year | 160.5 |
| Detailed Income Statement | FY 23-24 (in Cr) |
|---|---|
| 823.2 | |
| 888.8 | |
| Total profit before exceptional items, extraordinary items and tax | (65.6) |
| Exceptional items before tax | 0 |
| Total profit before tax | (65.6) |
| 9.2 | |
| Total profit (loss) for period from continuing operations | (74.8) |
| Total profit (loss) for period | (74.8) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 23-24 (in Cr) |
|---|---|
| 2,331.3 | |
| 2,331.3 |
| Detailed Cash Flow Statement | FY 23-24 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | 114.4 |
| Net cash from / (used in) investing activities | (380.0) |
| Net cash from / (used) in financing activities | 197.6 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (68.0) |
| Net increase / (decrease) in cash and cash equivalents | (68.0) |
| Cash and cash equivalents at the beginning of the year | 98.2 |
| Cash and cash equivalents at the end of the year | 30.2 |
| Detailed Income Statement | FY 22-23 (in Cr) |
|---|---|
| 456.1 | |
| 437.1 | |
| Total profit before exceptional items, extraordinary items and tax | 19.0 |
| Total profit before tax | 19.0 |
| 8.3 | |
| Total profit (loss) for period from continuing operations | 10.7 |
| Total profit (loss) for period | 10.7 |
| Basic earning per equity share | 0.0 |
| Diluted earnings per equity share | 0.0 |
| Detailed Balance Sheet | FY 22-23 (in Cr) |
|---|---|
| 1,587.3 | |
| 1,587.3 |
| Detailed Cash Flow Statement | FY 22-23 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | 186.0 |
| Net cash from / (used in) investing activities | (819.2) |
| Net cash from / (used) in financing activities | 723.5 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 90.3 |
| Net increase / (decrease) in cash and cash equivalents | 90.3 |
| Cash and cash equivalents at the beginning of the year | 8.0 |
| Cash and cash equivalents at the end of the year | 98.2 |
| Detailed Income Statement | FY 21-22 (in Cr) |
|---|---|
| 270.9 | |
| 862.1 | |
| Total profit before exceptional items, extraordinary items and tax | (591.2) |
| Total profit before tax | (591.2) |
| (2.9) | |
| Total profit (loss) for period from continuing operations | (588.3) |
| Total profit (loss) for period | (588.3) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 21-22 (in Cr) |
|---|---|
| 577.5 | |
| 577.5 |
| Detailed Cash Flow Statement | FY 21-22 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | 43.6 |
| Net cash from / (used in) investing activities | (117.6) |
| Net cash from / (used) in financing activities | 60.3 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (13.7) |
| Net increase / (decrease) in cash and cash equivalents | (13.7) |
| Cash and cash equivalents at the beginning of the year | 20.6 |
| Cash and cash equivalents at the end of the year | 6.9 |
| Detailed Income Statement | FY 20-21 (in Cr) |
|---|---|
| 149.4 | |
| 162.1 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (12.8) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (12.8) |
| Total profit before tax | (12.8) |
| (2.1) | |
| Total profit (loss) for period from continuing operations | (10.7) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period before minority interest | (10.7) |
| Profit (loss) of minority interest | 0 |
| Share of profit (loss) of associates | 0 |
| Total profit (loss) for period | (10.7) |
| Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations | 0 |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Nominal value of per equity share | 0.0 |
| Detailed Balance Sheet | FY 20-21 (in Cr) |
|---|---|
| 292.2 | |
| 292.2 |
| Detailed Cash Flow Statement | FY 20-21 (in Cr) |
|---|---|
| Cash flow from operating activities | 21.9 |
| Net cash from / (used in) operating activities | 21.9 |
| Cash flow from investing activities | (56.2) |
| Net cash from / (used in) investing activities | (56.2) |
| Cash flow from financing activities | 44.8 |
| Net cash from / (used) in financing activities | 44.8 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 10.5 |
| Effect of exchange rate changes on cash and cash equivalents | (0.0) |
| Net increase / (decrease) in cash and cash equivalents | 10.4 |
| Cash and cash equivalents at the beginning of the year | 10.2 |
| Cash and cash equivalents at the end of the year | 20.6 |
| Detailed Income Statement | FY 19-20 (in Cr) |
|---|---|
| 143.8 | |
| 147.6 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (3.8) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (3.8) |
| Total profit before tax | (3.8) |
| (1.0) | |
| Total profit (loss) for period from continuing operations | (2.8) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period before minority interest | (2.8) |
| Profit (loss) of minority interest | 0 |
| Share of profit (loss) of associates | 0 |
| Total profit (loss) for period | (2.8) |
| Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations | 0 |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Nominal value of per equity share | 0.0 |
| Detailed Balance Sheet | FY 19-20 (in Cr) |
|---|---|
| 244.6 | |
| 244.6 |
| Detailed Cash Flow Statement | FY 19-20 (in Cr) |
|---|---|
| Cash flow from operating activities | 18.2 |
| Net cash from / (used in) operating activities | 18.2 |
| Cash flow from investing activities | (70.1) |
| Net cash from / (used in) investing activities | (70.1) |
| Cash flow from financing activities | 57.7 |
| Net cash from / (used) in financing activities | 57.7 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 5.9 |
| Effect of exchange rate changes on cash and cash equivalents | (0.1) |
| Net increase / (decrease) in cash and cash equivalents | 5.8 |
| Cash and cash equivalents at the beginning of the year | 4.4 |
| Cash and cash equivalents at the end of the year | 10.2 |
| Detailed Income Statement | FY 18-19 (in Cr) |
|---|---|
| 129.8 | |
| 121.2 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | 8.6 |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | 8.6 |
| Total profit before tax | 8.6 |
| (3.7) | |
| Total profit (loss) for period from continuing operations | 12.3 |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period before minority interest | 12.3 |
| Profit (loss) of minority interest | 0 |
| Share of profit (loss) of associates | 0 |
| Total profit (loss) for period | 12.3 |
| Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations | 0 |
| Basic earning per equity share before extraordinary items | 0.0 |
| Diluted earnings per equity share before extraordinary items | 0.0 |
| Basic earning per equity share | 0.0 |
| Diluted earnings per equity share | 0.0 |
| Nominal value of per equity share | 0.0 |
| Detailed Balance Sheet | FY 18-19 (in Cr) |
|---|---|
| 177.6 | |
| 177.6 |
| Detailed Cash Flow Statement | FY 18-19 (in Cr) |
|---|---|
| Cash flow from operating activities | 14.7 |
| Net cash from / (used in) operating activities | 14.7 |
| Cash flow from investing activities | (56.9) |
| Net cash from / (used in) investing activities | (56.9) |
| Cash flow from financing activities | (7.1) |
| Net cash from / (used) in financing activities | (7.1) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (49.3) |
| Effect of exchange rate changes on cash and cash equivalents | (0.4) |
| Net increase / (decrease) in cash and cash equivalents | (49.7) |
| Cash and cash equivalents at the beginning of the year | 54.1 |
| Cash and cash equivalents at the end of the year | 4.4 |
| Detailed Income Statement | FY 17-18 (in Cr) |
|---|---|
| 110.0 | |
| 103.4 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | 6.6 |
| Exceptional items before tax | (1.0) |
| Total profit before extraordinary items and tax | 5.6 |
| Total profit before tax | 5.6 |
| 0.0 | |
| Total profit (loss) for period from continuing operations | 5.5 |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period before minority interest | 5.5 |
| Profit (loss) of minority interest | 0 |
| Share of profit (loss) of associates | 0 |
| Total profit (loss) for period | 5.5 |
| Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations | 0 |
| Basic earning per equity share before extraordinary items | 0.0 |
| Diluted earnings per equity share before extraordinary items | 0.0 |
| Basic earning per equity share | 0.0 |
| Diluted earnings per equity share | 0.0 |
| Nominal value of per equity share | 0.0 |
| Detailed Balance Sheet | FY 17-18 (in Cr) |
|---|---|
| 168.0 | |
| 168.0 |
| Detailed Cash Flow Statement | FY 17-18 (in Cr) |
|---|---|
| Cash flow from operating activities | 14.6 |
| Net cash from / (used in) operating activities | 14.6 |
| Cash flow from investing activities | (39.3) |
| Net cash from / (used in) investing activities | (39.3) |
| Cash flow from financing activities | 74.2 |
| Net cash from / (used) in financing activities | 74.2 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 49.5 |
| Effect of exchange rate changes on cash and cash equivalents | (0.0) |
| Net increase / (decrease) in cash and cash equivalents | 49.5 |
| Cash and cash equivalents at the beginning of the year | 4.5 |
| Cash and cash equivalents at the end of the year | 58.9 |
| Detailed Income Statement | FY 16-17 (in Cr) |
|---|---|
| 89.6 | |
| 85.3 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | 4.3 |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | 4.3 |
| Total profit before tax | 4.3 |
| 0.0 | |
| Total profit (loss) for period from continuing operations | 4.3 |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period before minority interest | 4.3 |
| Profit (loss) of minority interest | 0 |
| Share of profit (loss) of associates | 0 |
| Total profit (loss) for period | 4.3 |
| Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations | 0 |
| Basic earning per equity share before extraordinary items | 0.0 |
| Diluted earnings per equity share before extraordinary items | 0.0 |
| Basic earning per equity share | 0.0 |
| Diluted earnings per equity share | 0.0 |
| Nominal value of per equity share | 0.0 |
| Detailed Balance Sheet | FY 16-17 (in Cr) |
|---|---|
| 81.9 | |
| 81.9 |
| Detailed Cash Flow Statement | FY 16-17 (in Cr) |
|---|---|
| Cash flow from operating activities | 5.4 |
| Net cash from / (used in) operating activities | 5.4 |
| Cash flow from investing activities | (8.2) |
| Net cash from / (used in) investing activities | (8.2) |
| Cash flow from financing activities | (0.2) |
| Net cash from / (used) in financing activities | (0.2) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (3.1) |
| Effect of exchange rate changes on cash and cash equivalents | 0 |
| Net increase / (decrease) in cash and cash equivalents | (3.1) |
| Cash and cash equivalents at the beginning of the year | 7.6 |
| Cash and cash equivalents at the end of the year | 7.4 |
| Detailed Income Statement | FY 15-16 (in Cr) |
|---|---|
| 54.8 | |
| 65.1 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (10.4) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (10.4) |
| Total profit before tax | (10.4) |
| 0 | |
| Total profit (loss) for period from continuing operations | (10.4) |
| Detailed Balance Sheet | FY 15-16 (in Cr) |
|---|---|
| 72.0 | |
| 72.0 |
| Detailed Cash Flow Statement | FY 15-16 (in Cr) |
|---|
| Detailed Income Statement | FY 14-15 (in Cr) |
|---|---|
| 43.9 | |
| 55.0 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (11.1) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (11.1) |
| Extraordinary items before tax | 0 |
| Total profit before tax | (11.1) |
| (0.1) | |
| Total profit (loss) for period from continuing operations | (11.0) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | (11.0) |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 14-15 (in Cr) |
|---|---|
| 51.5 | |
| 51.5 |
| Detailed Cash Flow Statement | FY 14-15 (in Cr) |
|---|
| Detailed Income Statement | FY 13-14 (in Cr) |
|---|---|
| 26.8 | |
| 44.0 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (17.1) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (17.1) |
| Total profit before tax | (17.1) |
| 0.1 | |
| Total profit (loss) for period from continuing operations | (17.3) |
| Detailed Balance Sheet | FY 13-14 (in Cr) |
|---|---|
| 49.9 | |
| 49.9 |
| Detailed Cash Flow Statement | FY 13-14 (in Cr) |
|---|
As of Jun 30, 2025 • Asgeyehospital
| Shareholder | Category | Shares (Mn) | % Holding |
|---|---|---|---|
| General Atlantic Singapore ASGH Pte Ltd | Fund | 6.92M | 30.22% |
| Kedaara Capital Fund III Llp | Fund | 4.61M | 20.15% |
| Arun Singhvi | Founder | 3.63M | 15.86% |
| Britten Holdings | Enterprise | 2.12M | 9.26% |
| Sky Capitalvision Fund I | Fund | 1.87M | 8.18% |